Non-Hodgkin's Lymphoma
Showing NaN - NaN of 20
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
-
Atlanta, Georgia
- +2 more
Feb 9, 2022
Non-Hodgkin's Lymphoma Trial in United States (fludarabine and rituximab, fludarabine, rituximab, pixantrone)
Withdrawn
- Non-Hodgkin's Lymphoma
- fludarabine and rituximab
- fludarabine, rituximab, pixantrone
-
Muscle Shoals, Alabama
- +7 more
Oct 2, 2020
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)
Completed
- Non-Hodgkin's Lymphoma
-
Mobile, Alabama
- +120 more
Dec 20, 2019
Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)
Completed
- Follicular Lymphoma
- +2 more
-
Burbank, California
- +11 more
Mar 26, 2019
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Columbus (Velcade, Rituximab)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
-
Columbus, OhioOhio State University Medical Center
Mar 7, 2018
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
- bendamustine
- +5 more
-
Tucson, Arizona
- +127 more
Jan 8, 2018
Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease Trial in United States
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- +3 more
-
Los Angeles, California
- +19 more
Nov 20, 2015
Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)
Completed
- Non-Hodgkin's Lymphoma
- obinutuzumab (RO5072759)
- rituximab
-
Los angeles, California
- +70 more
Aug 15, 2014
Non-Hodgkin's Lymphoma Trial in Australia, Canada, United States (bendamustine and rituximab)
Completed
- Non-Hodgkin's Lymphoma
- bendamustine and rituximab
-
Anchorage, Alaska
- +33 more
May 8, 2014
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Australia, Canada, United States (Bendamustine, Rituximab)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
-
Tucson, Arizona
- +42 more
Apr 7, 2014
Acute Leukemia, Chronic Leukemia, Multiple Myeloma Trial in United States (AVN-944 capsules for oral administration)
Completed
- Acute Leukemia
- +5 more
- AVN-944 capsules for oral administration
-
Tucson, Arizona
- +4 more
Aug 2, 2011
Non-Hodgkin's Lymphoma Trial in United States (Id-KLH)
Unknown status
- Non-Hodgkin's Lymphoma
- Id-KLH
-
La Jolla, California
- +14 more
Sep 29, 2009
Non-Hodgkin's Lymphoma Trial in United States (Xcellerated T Cells)
Unknown status
- Non-Hodgkin's Lymphoma
- Xcellerated T Cells
-
Greenbrae, California
- +17 more
Jun 23, 2005